Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Revenue: 2010-2025

Historic Revenue for Niagen Bioscience (NAGE) over the last 14 years, with Sep 2025 value amounting to $34.0 million.

  • Niagen Bioscience's Revenue rose 32.86% to $34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.7 million, marking a year-over-year increase of 36.04%. This contributed to the annual value of $99.6 million for FY2024, which is 19.18% up from last year.
  • Niagen Bioscience's Revenue amounted to $34.0 million in Q3 2025, which was up 9.22% from $31.1 million recorded in Q2 2025.
  • Niagen Bioscience's 5-year Revenue high stood at $34.0 million for Q3 2025, and its period low was $14.7 million during Q1 2021.
  • Moreover, its 3-year median value for Revenue was $22.7 million (2024), whereas its average is $25.3 million.
  • As far as peak fluctuations go, Niagen Bioscience's Revenue decreased by 5.46% in 2022, and later surged by 37.59% in 2025.
  • Quarterly analysis of 5 years shows Niagen Bioscience's Revenue stood at $17.8 million in 2021, then rose by 18.23% to $21.0 million in 2022, then increased by 0.95% to $21.2 million in 2023, then spiked by 37.41% to $29.1 million in 2024, then spiked by 32.86% to $34.0 million in 2025.
  • Its Revenue stands at $34.0 million for Q3 2025, versus $31.1 million for Q2 2025 and $30.5 million for Q1 2025.